Lisa M. DeAngelis

Active 1975–2025

182
Papers
41,006
Citations
112
h-index
180
i10-index

Citations

Citations per year for Lisa M. DeAngelis1967: 1 citations1976: 1 citations1977: 1 citations1980: 3 citations1981: 1 citations1982: 2 citations1983: 1 citations1986: 2 citations1988: 1 citations1989: 4 citations1990: 1 citations1991: 7 citations1992: 16 citations1993: 12 citations1994: 19 citations1995: 17 citations1996: 33 citations1997: 25 citations1998: 42 citations1999: 75 citations2000: 84 citations2001: 74 citations2002: 108 citations2003: 144 citations2004: 172 citations2005: 154 citations2006: 173 citations2007: 169 citations2008: 205 citations2009: 258 citations2010: 253 citations2011: 299 citations2012: 253 citations2013: 244 citations2014: 242 citations2015: 253 citations2016: 251 citations2017: 293 citations2018: 266 citations2019: 1,128 citations2020: 1,580 citations2021: 1,498 citations2022: 1,240 citations2023: 875 citations2024: 1,229 citations2025: 451 citations2026: 11 citations1968–1975: no citations, so these years are not shown1978–1979: no citations, so these years are not shown1984–1985: no citations, so these years are not shown1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,029 citing papers, 29.7% of this breakdownChina: 1,674 citing papers, 12.4% of this breakdownGermany: 824 citing papers, 6.1% of this breakdownItaly: 720 citing papers, 5.3% of this breakdownUnited Kingdom: 625 citing papers, 4.6% of this breakdownFrance: 585 citing papers, 4.3% of this breakdownNetherlands: 458 citing papers, 3.4% of this breakdownCanada: 454 citing papers, 3.4% of this breakdownSwitzerland: 355 citing papers, 2.6% of this breakdownJapan: 337 citing papers, 2.5% of this breakdownSpain: 322 citing papers, 2.4% of this breakdownAustralia: 301 citing papers, 2.2% of this breakdown
0%29.7%Other 21.1%

Fields

  • Medicine74.4%
  • Biochemistry, Genetics and Molecular Biology15.7%
  • Neuroscience3.2%
  • Immunology and Microbiology2.7%
  • Chemistry0.9%
  • Engineering0.8%
  • Other2.3%

Topics

  • Glioma Diagnosis and Treatment11.1%
  • Brain Metastases and Treatment5.4%
  • Cancer Immunotherapy and Biomarkers5.1%
  • CNS Lymphoma Diagnosis and Treatment3.1%
  • Cancer Genomics and Diagnostics3.1%
  • CAR-T cell therapy research2.9%
  • Other69.3%

Coauthors

All papers

Open in search
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  2. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 924

  3. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 650

  4. Brain Tumors

    Authors: - New England Journal of Medicine 2001 cited by 1,645

  5. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 906

  6. An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2011 cited by 447

  7. Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 437

  8. BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 331

  9. Risk of Arterial Thromboembolism in Patients With Cancer

    Authors: , , , , , , , - Journal of the American College of Cardiology 2017 cited by 646

  10. Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 142

  11. Primary CNS Lymphoma

    Authors: , - Journal of Clinical Oncology 2017 cited by 578

  12. EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science Signaling 2009 cited by 344

  13. The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 cited by 244

  14. Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Glass, Scott Peak, Enrico C. Lallana, Vaios Hatzoglou, Anne S. Reiner, Philip H. Gutin, Jason T. Huse, Katherine S. Panageas, Thomas G. Graeber, Nikolaus Schultz, Lisa M. DeAngelis, Ingo K. Mellinghoff - Cancer Discovery 2017 cited by 402

  15. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lakshmi Nayak, James R. Heath, Laura L. Horky, Tracy T. Batchelor, Rameen Beroukhim, Susan M. Chang, Azra H. Ligon, Ian F. Dunn, Dimpy Koul, Geoffrey S. Young, Michael D. Prados, David A. Reardon, W.K. Alfred Yung, Keith L. Ligon - Journal of Clinical Oncology 2019 cited by 155

  16. Cancer-treatment-induced neurotoxicity—focus on newer treatments

    Authors: , - Nature Reviews Clinical Oncology 2015 cited by 274

  17. Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Grommes, Adrienne Boire, Mariza Daras, Anna F. Piotrowski, Alexandra Miller, Philip H. Gutin, Timothy A. Chan, Viviane Tabar, Cameron Brennan, Marc K. Rosenblum, Lisa M. DeAngelis, Ingo K. Mellinghoff, Barry S. Taylor - Clinical Cancer Research 2019 cited by 156

  18. Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2018 cited by 246

  19. Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nian Wu, Andrew B. Lassman, Lisa M. DeAngelis, William H. Yong, John G. Kuhn, Paul S. Mischel, Minesh P. Mehta, Timothy F. Cloughesy, Ingo K. Mellinghoff - Cancer Discovery 2012 cited by 344

  20. Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2006 cited by 620

  21. Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2018 cited by 219

  22. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

    Authors: , , , , , , , , , , , , , , - Blood 2015 cited by 345

  23. Cancer and Embolic Stroke of Undetermined Source

    Authors: , , , , , - Stroke 2021 cited by 161

  24. Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 491